Table 5.
Economic cost according to risk factor (n = 28)
| Cost (USD)‡ | ||||||
|---|---|---|---|---|---|---|
| Characteristics | All (n = 28) | Mechanical ventilation (n = 13) | ||||
| Median | Range | P‐value† | Median | Range | P‐value† | |
| No risk | 1,898.8 | 556.1–30 448.9 | 4,634.3 | 2,311.9–30 448.9 | ||
| Risk | 2,284.0 | 705.4–98 243.1 | 0.38 | 15 346.3 | 2,575.5–91 545.9 | 0.47 |
| Subgroup analysis | 0.74 | 0.65 | ||||
| CLD | 1,865.9 | 824.6–38 340.4 | 20 457.9 | 2,575.5–38 340.4 | ||
| HS‐CHD | 3,729.9 | 705.4–35 040.7 | 9,836.1 | 4,071.0–32 198.8 | ||
| NMD/CAA | 9,928.8 | 1,125.1–98 243.1 | 20 226.3 | 10 466.2–91 545.9 | ||
†Mann–Whitney test using exact method. ‡Exchange rate on 15 March 2016: 1 USD = 1212.5 KRW. CAA, congenital abnormality of the airway; CLD, chronic lung disease; HS‐CHD, hemodynamically significant congenital heart disease; NMD, neuromuscular disorder.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.